Journal
JOURNAL OF PAIN RESEARCH
Volume 11, Issue -, Pages 2145-2159Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/JPR.S144631
Keywords
acceptance and commitment therapy; chronic pain; review; assessment; clinical evidence; cost-effectiveness
Categories
Funding
- Instituto de Salud Carlos III (ISCIII) [CD16/00147]
- National Institute for Health Research (NIHR Postdoctoral Fellowship) [PDF-2015-08-059]
- National Institute for Health Research (NIHR) Biomedical Research Center at South London and Maudsley NHS Foundation Trust
- King's College London in the UK
- ISCIII [CP14/00087]
- Network for Prevention and Health Promotion in Primary Care [RD16/0007/0012]
Ask authors/readers for more resources
It is well known that chronic pain is prevalent, complex to manage, and associated with high costs, in health care and society in general. Thanks to advances in new forms of cognitive behavioral therapy (known as third-wave CBT), currently clinicians and researchers have an empirically validated psychological treatment with increasing research support for the treatment of chronic pain. This treatment is called acceptance and commitment therapy (ACT). The main aim of this paper is to provide a narrative review that summarizes and integrates the current state of knowledge of ACT in the management of chronic pain as well as discuss current challenges and opportunities for progress. Based on the psychological flexibility model, ACT extends previous forms of CBT and integrates many CBT-related variables into six core therapeutic processes. ACT is a process-based therapy that fosters openness, awareness, and engagement through a wide range of methods, including exposure-based and experiential methods, metaphors, and values clarification. To our knowledge, there are three published systematic reviews and meta-analyses that support the effectiveness of ACT for chronic pain and many studies focused on specific processes derived from the psychological flexibility model. There is also promising support for the cost-effectiveness of ACT; however, the current evidence is still insufficient to establish firm conclusions about cost-effectiveness and the most efficient means of delivery. Additional well-designed economic evaluations are needed. Other research aims include delineating the neurobiological underpinnings of ACT, refining available outcome and process measures or develop new ones for ACT trials, and meeting the challenge of wide dissemination and implementation in real-world clinical practice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available